Wall Street Analysts See Abercrombie (ANF) as a Buy: Should You Invest?

Despite Abercrombie & Fitch (ANF) holding an Average Brokerage Recommendation (ABR) of 1.90, indicating a 'Buy' equivalent, the article advises caution, citing the inherent positive bias in sell-side ratings. It highlights that ANF's Zacks Consensus Estimate for current year EPS has recently declined 0.1% to $10.17, leading to a Zacks Rank #4 (Sell). This divergence suggests that while analyst sentiment is broadly positive, underlying earnings estimate revisions point to potential near-term downside, urging investors to scrutinize ABRs against more objective metrics like the Zacks Rank.

Analysis

A notable divergence has emerged in the outlook for Abercrombie & Fitch (ANF), creating a conflicting signal for investors. On one hand, the company holds a favorable Average Brokerage Recommendation (ABR) of 1.90 on a 1-to-5 scale, which is equivalent to a 'Buy' rating. This is based on the consensus of 10 brokerage firms, where 60% of analysts rate the stock as either 'Strong Buy' (five analysts) or 'Buy' (one analyst). However, this positive sentiment is directly challenged by a more quantitative, earnings-focused metric. The Zacks Consensus Estimate for ANF's current-year EPS has declined by 0.1% over the last month to $10.17, reflecting growing pessimism among analysts about near-term earnings prospects. This negative trend in earnings estimate revisions has resulted in the company receiving a Zacks Rank #4 (Sell), suggesting a higher probability of underperformance in the near future and highlighting the potential unreliability of positively-biased sell-side ratings.

Key Decisions for Investors

• Investors should treat the 'Buy'-equivalent Average Brokerage Recommendation for ANF with caution, as it conflicts with negative underlying earnings estimate revisions.
• The recent 0.1% downward revision in the consensus EPS estimate to $10.17, while minor, is presented as a key bearish indicator, warranting closer scrutiny of the company's near-term earnings power.
• Given the Zacks Rank #4 (Sell) designation, it may be prudent to re-evaluate long positions or delay new investments until there is a clear reversal toward positive earnings estimate revisions.